FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2791541243> ?p ?o ?g. }

• W2791541243 endingPage "e0191920" @default.
• W2791541243 startingPage "e0191920" @default.
• W2791541243 abstract "Background Viral load (VL) monitoring of HIV-infected patients in decentralized areas is limited due to logistic constraints. Dried Blood Spots (DBS) offer the opportunity to collect samples in remote area which can be easily transferred and tested at a central laboratory. The MOVIDA (Monitoring Of Viral load In Decentralized Area) project evaluated the performance of VL measurements on DBS using the new CE marked optimized Abbott protocol. Methods HIV-1 infected adults from three outpatient clinics in Hanoi (Vietnam) were enrolled into the study between 1 March and 13 April 2017. VL was measured on DBS using the optimized protocol provided by the manufacturer and compared to plasma VL as reference method on the Abbott m2000rt RealTime HIV-1 platform. Sensitivity was defined as the ability for DBS samples to correctly identify VL failure at the threshold of 1000 copies/mL of plasma, while specificity represented the ability to identify patients with a plasma HIV-RNA VL of <1000 copies/mL. Results A total of 203 patients were enrolled in the study, of which 152 (75%) were male. Median age was 38 [inter quartile range: 34–43] years. Of these patients, 37 were untreated, 38 on ART for <6 months and 117 were on ART for ≥6 months. A strong correlation between VL results in plasma and from DBS was observed (ρ = 0.95; p<0.001). Plasma VL was ≥1000 copies/mL in 71 patients. The sensitivity of DBS was 90.1% (95% confidence interval [CI]: 80.7–95.9) and the specificity was 96.2% (95% CI: 91.4–98.8). Conclusions The new optimized Abbott DBS protocol performed well in this study, meeting the WHO performance criteria for the use of DBS for HIV VL monitoring. Scaling up VL monitoring using DBS can be used to reach the last 90 in the UNAIDS targets of 90-90-90 to help end the AIDS epidemics. However, sensitivity remains the main challenge for manufacturers to prevent maintaining patients in virological failure on inefficient ART." @default.
• W2791541243 created "2018-03-29" @default.
• W2791541243 creator A5000281731 @default.
• W2791541243 creator A5002814903 @default.
• W2791541243 creator A5003514944 @default.
• W2791541243 creator A5008771904 @default.
• W2791541243 creator A5015663884 @default.
• W2791541243 creator A5036287831 @default.
• W2791541243 creator A5040166642 @default.
• W2791541243 creator A5040211967 @default.
• W2791541243 creator A5043653746 @default.
• W2791541243 creator A5049775977 @default.
• W2791541243 creator A5060071612 @default.
• W2791541243 creator A5072383075 @default.
• W2791541243 creator A5074500363 @default.
• W2791541243 creator A5074617773 @default.
• W2791541243 creator A5081233409 @default.
• W2791541243 creator A5085838012 @default.
• W2791541243 creator A5091138806 @default.
• W2791541243 date "2018-02-09" @default.
• W2791541243 modified "2023-10-18" @default.
• W2791541243 title "First field evaluation of the optimized CE marked Abbott protocol for HIV RNA testing on dried blood spot in a routine clinical setting in Vietnam" @default.
• W2791541243 cites W1600314899 @default.
• W2791541243 cites W162462373 @default.
• W2791541243 cites W1967245808 @default.
• W2791541243 cites W1970633445 @default.
• W2791541243 cites W1978981985 @default.
• W2791541243 cites W1989372408 @default.
• W2791541243 cites W2001632118 @default.
• W2791541243 cites W2013989770 @default.
• W2791541243 cites W2022496141 @default.
• W2791541243 cites W2022530456 @default.
• W2791541243 cites W2023250943 @default.
• W2791541243 cites W2113642360 @default.
• W2791541243 cites W2143326808 @default.
• W2791541243 cites W2149701672 @default.
• W2791541243 cites W2239032355 @default.
• W2791541243 cites W2303621293 @default.
• W2791541243 cites W2469427043 @default.
• W2791541243 cites W2492945986 @default.
• W2791541243 cites W2510088243 @default.
• W2791541243 cites W2559421547 @default.
• W2791541243 cites W2561581586 @default.
• W2791541243 cites W2562145008 @default.
• W2791541243 cites W2576907399 @default.
• W2791541243 cites W2594610194 @default.
• W2791541243 cites W2610629952 @default.
• W2791541243 cites W4210311257 @default.
• W2791541243 doi "https://doi.org/10.1371/journal.pone.0191920" @default.
• W2791541243 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5806875" @default.
• W2791541243 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29425216" @default.
• W2791541243 hasPublicationYear "2018" @default.
• W2791541243 type Work @default.
• W2791541243 sameAs 2791541243 @default.
• W2791541243 citedByCount "12" @default.
• W2791541243 countsByYear W27915412432019 @default.
• W2791541243 countsByYear W27915412432020 @default.
• W2791541243 countsByYear W27915412432021 @default.
• W2791541243 countsByYear W27915412432022 @default.
• W2791541243 countsByYear W27915412432023 @default.
• W2791541243 crossrefType "journal-article" @default.
• W2791541243 hasAuthorship W2791541243A5000281731 @default.
• W2791541243 hasAuthorship W2791541243A5002814903 @default.
• W2791541243 hasAuthorship W2791541243A5003514944 @default.
• W2791541243 hasAuthorship W2791541243A5008771904 @default.
• W2791541243 hasAuthorship W2791541243A5015663884 @default.
• W2791541243 hasAuthorship W2791541243A5036287831 @default.
• W2791541243 hasAuthorship W2791541243A5040166642 @default.
• W2791541243 hasAuthorship W2791541243A5040211967 @default.
• W2791541243 hasAuthorship W2791541243A5043653746 @default.
• W2791541243 hasAuthorship W2791541243A5049775977 @default.
• W2791541243 hasAuthorship W2791541243A5060071612 @default.
• W2791541243 hasAuthorship W2791541243A5072383075 @default.
• W2791541243 hasAuthorship W2791541243A5074500363 @default.
• W2791541243 hasAuthorship W2791541243A5074617773 @default.
• W2791541243 hasAuthorship W2791541243A5081233409 @default.
• W2791541243 hasAuthorship W2791541243A5085838012 @default.
• W2791541243 hasAuthorship W2791541243A5091138806 @default.
• W2791541243 hasBestOaLocation W27915412431 @default.
• W2791541243 hasConcept C126322002 @default.
• W2791541243 hasConcept C142462285 @default.
• W2791541243 hasConcept C185592680 @default.
• W2791541243 hasConcept C203014093 @default.
• W2791541243 hasConcept C2776597655 @default.
• W2791541243 hasConcept C3013748606 @default.
• W2791541243 hasConcept C3017516299 @default.
• W2791541243 hasConcept C43617362 @default.
• W2791541243 hasConcept C44249647 @default.
• W2791541243 hasConcept C54355233 @default.
• W2791541243 hasConcept C68443243 @default.
• W2791541243 hasConcept C71924100 @default.
• W2791541243 hasConcept C86803240 @default.
• W2791541243 hasConceptScore W2791541243C126322002 @default.
• W2791541243 hasConceptScore W2791541243C142462285 @default.
• W2791541243 hasConceptScore W2791541243C185592680 @default.
• W2791541243 hasConceptScore W2791541243C203014093 @default.
• W2791541243 hasConceptScore W2791541243C2776597655 @default.
• W2791541243 hasConceptScore W2791541243C3013748606 @default.

• next